aTYR Pharma Inc.
- Address
- 10240 Sorrento Valley Road Suite 300
Sponsor Overview
Specializations
Respiratory Inflammatory Disease
aTyr Pharma Inc. is focused on clinical research in pulmonary sarcoidosis, a chronic inflammatory lung disease marked by immune-driven involvement of the respiratory system.
- Pulmonary sarcoidosis
- Inflammation of the lungs
- Immune-mediated respiratory disease
The sponsor’s research activity in this area centers on treatment options for patients with lung involvement and related respiratory impairment.
Immunology
The company’s trial portfolio reflects interest in immune regulation and disease mechanisms associated with granulomatous inflammation in the lungs.
- Immune dysfunction
- Granulomatous disease
- Inflammatory pathways
Its clinical work in this field is directed toward conditions where abnormal immune activity contributes to persistent pulmonary symptoms.
Biologic Therapeutics
aTyr Pharma Inc. is engaged in development efforts involving biologic therapy for a respiratory indication, with attention to therapies designed for systemic inflammatory disorders affecting the lungs.
- Biologic medicines
- Targeted immunomodulation
- Intravenous treatment
This therapeutic area connects the sponsor’s research with precision approaches for inflammatory disease management.
Clinical Development in Rare Disease
The sponsor’s clinical research includes a rare pulmonary disorder studied across multiple international sites, indicating involvement in disease areas with limited treatment options.
- Rare disease research
- Multinational clinical care
- Specialty respiratory medicine
Its work supports therapeutic investigation in a specialized medical setting for patients with uncommon lung disease.
Sponsored Trials
| Trial Name | Country | Status |
|---|---|---|
| Phase 3 Randomized Double-Blind Placebo-Controlled Trial Evaluating Intravenous Efzofitimod Efficacy and Safety in Pulmonary Sarcoidosis Patients |  France Germany Italy Spain The Netherlands | Not Recruiting |
Data & Insights
This sponsor works with 1 molecule, of which 1 is not being studied by other sponsors.
This sponsor has worked with 26 sites across their trial portfolio.
Therapeutic Focus
- 1.Immune System Diseases1 trial322 other sponsors
Partnered Research Centres
26 centres- Address
- Meibergdreef 9, 1105 AZ Amsterdam
- Address
- Num Voie 47 A 83, 47 Boulevard De L Hopital, 75013 Paris
- Address
- Via Nicolo' Giustiniani 2, 35128 Padua
- Address
- Via Sergio Pansini 5, 80131 Naples
- Address
- Strada Delle Scotte 14, 53100 Siena
- Address
- Largo Giovanni Alessandro Brambilla 3, 50134 Florence
Want to get in touch with this sponsor?
Send a question and we'll pass it on to aTYR Pharma Inc..
Need a custom report on this sponsor?
Competitive positioning, market entry, partnership opportunities — tell us the question.
Is something out of date?
Tell us what needs correcting and we'll update this profile.